Question 1

Why is this test needed?

Accepted Answer

To differentiate between benign prostate conditions and cancer. To reduce the number of unnecessary and invasive prostate biopsies. To evaluate cases with slightly elevated total PSA levels.

Question 2

Target Groups

Accepted Answer

Men aged 50 and older. Individuals with a family history of prostate cancer. Men with total PSA levels in the 'gray zone' (4-10 ng/mL).

Question 3

Benefits of the PHI Test

Accepted Answer

Three times more specific for prostate cancer than PSA alone. Assists physicians in making more informed biopsy decisions. Provides a single, comprehensive risk score for clinical clarity.

Advanced Prostate Cancer Risk Assessment - Prostate Health Index (PHI) Test